Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in BRCA1 who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy - Scorecard - MDSpire
Advertisement
Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in BRCA1 who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy
Clinical Scorecard: Clinical Case Study: Pregnancy-Related Breast Cancer in a Patient with a BRCA1 Pathogenic Variant Undergoing Sequential Risk-Reducing Salpingo-Oophorectomy and Contralateral Mastectomy
At a Glance
Category
Detail
Condition
Key Mechanisms
Increased risk of breast and ovarian cancers due to BRCA1/2 variants; management includes risk-reducing surgeries and individualized treatment plans.
Target Population
Care Setting
Key Highlights
Patient diagnosed with luminal B-like, stage IIA breast cancer at 8 weeks of pregnancy, with a history of previous pregnancy loss due to anencephaly.
Guideline-Based Recommendations
Diagnosis
Confirm breast cancer diagnosis with imaging and biopsy, including ultrasound and MRI when safe.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Adjuvant chemotherapy with doxorubicin and cyclophosphamide can be safely administered during pregnancy, supported by recent studies.
Clinical Best Practices
Engage in multidisciplinary consultations involving oncologists, obstetricians, and genetic counselors for complex cases.
